| LUMO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUMO shares outstanding history going back to 3/19/2020:
Also see: LUMO Market Cap History LUMO YTD Return |
As of 11/5/2024 NewLink Genetics has 8.65 million LUMO shares outstanding. Investors often track the LUMO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LUMO share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 3/19/2020.

| LUMO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUMO shares outstanding history going back to 3/19/2020:
Also see: LUMO Market Cap History LUMO YTD Return |
| LUMO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
LUMO Historical Shares Outstanding: +17.18% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| LUMO Stock Price Chart |
| About Lumos Pharma Inc |
| Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in advancing its clinical program and focused on identifying, acquiring, developing, and commercializing products and new therapies for people with rare diseases. Its pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders that require injectable recombinant human growth hormone (rhGH). LUM-201 is a tablet formulation that is intended to be administered once daily. We show 21 historical shares outstanding datapoints in our coverage of LUMO's shares outstanding history. Understanding the changing numbers of LUMO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LUMO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LUMO by allowing them to research LUMO shares outstanding history as well as any other stock in our coverage universe. |
| LUMO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| LUMO Share Performance |
| Shares Outstanding Peers |
| NewLink Genetics (LUMO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LUNG Shares Outstanding History LVGO Shares Outstanding History LXEO Shares Outstanding History LXRX Shares Outstanding History LYEL Shares Outstanding History LYRA Shares Outstanding History MACK Shares Outstanding History MASI Shares Outstanding History MBIO Shares Outstanding History MBOT Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.